Global market for STD-AIDS
Sexually transmitted diseases are one of the most critical health challenges facing in today’s world. Generally, patients suffering from STDs are mainly within 15 to 44 years, and ~500 million new cases of STDs are registered per year. The STDs global testing market was valued at $107,024 million in 2015, and estimated to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. The growth in the market is primarily attributed to the high growth in HIV and HPV testing, especially in Asia Pacific and African regions along with complimenting growth rate of the European market. Microfluidics is probable grow fastest, growing at a CAGR of 34.2% owing to the ease of use, technological advancements, and quick results in diagnostics.